SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Axovant Gene Therapies Q2 EPS $(0.61) Down From $(0.28) YoY

Axovant Gene Therapies (NASDAQ:AXGT) reported quarterly losses of $(0.61) per share. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year.

Benzinga · -

Axovant Gene Therapies (NASDAQ:AXGT) reported quarterly losses of $(0.61) per share. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year.